Pharmaceuticals

  • RheumaGen

    Website RheumaGen is a private biotechnology company engineering a new class of therapeutic to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado.

  • HepQuant

    Website HepQuant develops non-invasive, quantitative tests that measure liver health. The HepQuant DuO Test is a Laboratory Developed Test (LDT) that enables healthcare providers to manage patients with liver diseases more effectively. It delivers information about liver cell function and portal-systemic shunting, attributes of liver disease that are associated with clinical outcomes. Results may be…

  • Vona Oncology

    Website Vona Oncology is an early clinical stage bio-pharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer (TNBC), ovarian cancer, and melanoma. TNBC is the initial indication for Vona’s small molecule drug, VDX-111.

  • PharmaLogic

    Website PharmaLogic is a North American radiopharmaceutical and Mobile PET/CT operations company, dedicated to nuclear medicine and the science of radiopharmaceutical production. Their commitment to these fields extends to the communities they serve. They further differentiate by offering a unique suite of solutions addressing the dynamic challenges facing the nuclear imaging market. PharmaLogic utilizes a…

  • Pathways Bioscience

    Website At Pathways Bioscience, we believe that the best way to improve health span and overcome health and wellness problems associated with aging is to support the body’s own defense mechanisms that allow it to protect and heal itself. We are focused on the discovery and development of new agents that regulate gene expression and…

  • Op-T, LLC

    Website Op-T is a clinical-stage company that has developed a new therapeutic for controlling inflammation in autoimmune diseases, acute inflammatory conditions, and certain chronic conditions across multiple species. The company has received IND approvals from the FDA for Phase 1 studies in humans with type 1 diabetes (T1D) and in healthy humans toward later studies…

  • Machavert Pharmaceuticals

    Website Machavert is a pharmaceutical company that develops first-in-class targeted therapeutics to treat cancer. Machavert’a approach takes advantage of proprietary RAL GTPase inhibitors to control KRAS mutant cancer growth and metastasis to improve the lives of patients suffering from difficult-to-treat cancers. Machavert currently focuses on the development of novel RAL GTPase inhibitors for IND enabling…

  • Lohocla Research Corporation

    Website Lohocla Research Corporation is dedicated to making a difference in improving people’s lives. A compassionate company committed to improving quality of life, Lohocla’s mission is to use genetic and genomic technology and biochemical and molecular-biology approaches in conjunction with rational computational drug design to develop diagnostic and therapeutic products for chronic pain, neurologic mental…